Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_124da6fd3109b646948e2eaf47a8fac5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0828c475d55eaf1300940a2a6cd96210 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eef170cd6b29b16be4f35faf75f62720 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1c8ec1f1e7a71351775e7986f8ffae6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-0253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465 |
filingDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51450e53bb22f786ba5f8c3db194b7be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e95468d4865ff2d35eb4c87d555554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_302f99b1e91e7c6d195b9dc3a944ffce |
publicationDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012029447-A1 |
titleOfInvention |
Transdermal pharmaceutical preparation and administration of tirofiban |
abstract |
The present invention provides a titratable transdermal drug delivery system comprising an effective dose of an antithrombotic agent, such as tirofiban, or a pharmaceutically acceptable salt thereof. The dosage of the drug delivered is proportional to the size of the patch applied and achieves 60-85% platelet inhibition. The system enables and individualized treatment for patients. Also provided are methods for the treatment of various disorders where platelet inhibition is desired. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114984330-A |
priorityDate |
2009-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |